Newsletter Sept 2014
19 Feb 2015
WWARN Published Date
· WWARN’s new literature review summarises the global extent of reduced P. vivax susceptibility to the frontline antimalarial chloroquine.- · The WWARN team will be taking part in the BMC Challenges in Malaria Conference and the Royal Society of Tropical Medicine & Hygiene Biennial Meeting, both in Oxford.
- · The WWARN Molecular Surveyor now includes molecular markers of antimalarial drug resistance found on genes pfcrt and pfmdr1.
- · A team of researchers led by Prof Paul Newton, Head of WWARN’s Antimalarial Quality Group, discuss the implications of a large seizure of falsified medicines, including antimalarials, in Angola.
- · Two new research papers are enhancing our understanding of antimalarial resistance.